Introduction Chimeric antigen receptors (CAR) consisting of an extracellular anti-body based single chain variable fragment (scFv) linked to a transmembrane and intracellular signaling domain can boost anti-tumor activities of effector cells. In this study, we focused on membrane-bound heat shock protein 70 (mHsp70) as a tumor specific target for the recognition by an anti-mHsp70 CAR in NK cell lines. We focused on targeting HNSCC tumors, due to limited treatment options available for late-stage tumors.
No takes yet. Share an insight, caveat, or question.
Trill et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: